These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 20025486

  • 1. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
    Chiu W, Pullon H, Woon ST, Oei P, The R, Ameratunga R.
    Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
    [No Abstract] [Full Text] [Related]

  • 2. Kappa light chain myeloma with initial cutaneous involvement.
    Saka B, Erten N, Oztürk G, Yilmaz C, Dogan O, Buyukbabani N, Besisik SK.
    Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
    [No Abstract] [Full Text] [Related]

  • 3. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M, Frikha M, Masmoudi H, Mseddi S, Ben Ayed M, Bouaziz M, Makni F, Souissi T.
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [Abstract] [Full Text] [Related]

  • 4. IgE myeloma. Report of a new case and review of the literature.
    Sala P, Tonutti E, Ruscio M, Colle R, Antonutto G, Falconieri G.
    Haematologica; 1981 Dec; 66(6):787-95. PubMed ID: 6802719
    [No Abstract] [Full Text] [Related]

  • 5. [IgM myeloma].
    Assaf ME, Pizzolato MA, De María HE, Gasparini S, Burucua JE.
    Sangre (Barc); 1983 Dec; 28(5):642-7. PubMed ID: 6420914
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of plasma cell myeloma with cytotoxic agents.
    Bergsagel DE, Pruzanski W.
    Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363
    [Abstract] [Full Text] [Related]

  • 7. A rare complication of monoclonal gammopathy.
    Nasr SH, Lobritto SJ, Lauring BP, Arend LJ, D'Agati VD, Markowitz GS.
    Am J Kidney Dis; 2002 Oct; 40(4):867-71. PubMed ID: 12324928
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA, Pierre RV, Bayrd ED.
    Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
    [Abstract] [Full Text] [Related]

  • 10. [Plasma cell leukaemia. Haematological features and response to treatment (author's transl)].
    Fernández Rañada JM, Ribera C, López Pascual J, Salazar DG, Talero D, Montero J.
    Sangre (Barc); 1975 Jan; 20(4):498-504. PubMed ID: 1216078
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients.
    Matzner Y, Benbassat J, Polliack A.
    Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296
    [No Abstract] [Full Text] [Related]

  • 12. IgE response in multiple myeloma.
    Tamir R, Barchat I, Weiss H, Pick AI.
    Ann Allergy; 1993 Mar; 70(3):214-7. PubMed ID: 8452316
    [Abstract] [Full Text] [Related]

  • 13. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
    Yeh YA, Pappas AA, Flick JT, Butch AW.
    Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
    [Abstract] [Full Text] [Related]

  • 14. [Pleural effusion as a first sign of Ig D lambda multiple myeloma].
    Maachi M, Fellahi S, Diop ME, Francois T, Capeau J, Bastard JP.
    Ann Med Interne (Paris); 2003 Feb; 154(1):70-2. PubMed ID: 12746663
    [Abstract] [Full Text] [Related]

  • 15. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A.
    Cancer Res; 1998 Jan 15; 58(2):256-62. PubMed ID: 9443402
    [Abstract] [Full Text] [Related]

  • 16. Two cases of plasma cell leukemia with atypical immunophenotype.
    Buda G, Carulli G, Orciuolo E, Cannizzo E, Zucca A, Azzarà A, Rossi A, Galimberti S, Cecconi N, Petrini M.
    Acta Haematol; 2007 Jan 15; 118(1):27-9. PubMed ID: 17429194
    [No Abstract] [Full Text] [Related]

  • 17. New strategies for MGUS and smoldering multiple myeloma.
    Kyle RA.
    Clin Adv Hematol Oncol; 2004 Aug 15; 2(8):507, 509. PubMed ID: 16163229
    [No Abstract] [Full Text] [Related]

  • 18. Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma.
    Cabrera R, Díaz-Espada F, Barrios Y, Briz M, Forés R, Barbolla L, Sanjuán I, Regidor C, Peñalver FJ, Fernández MN.
    Bone Marrow Transplant; 2000 May 15; 25(10):1105-8. PubMed ID: 10828874
    [Abstract] [Full Text] [Related]

  • 19. Auer rod-like intracytoplasmic inclusions in multiple myeloma. A case report and review of the literature.
    Hütter G, Nowak D, Blau IW, Thiel E.
    Int J Lab Hematol; 2009 Apr 15; 31(2):236-40. PubMed ID: 18190590
    [Abstract] [Full Text] [Related]

  • 20. [A myeloma (IgG-kappa) terminating in acute myelogenous leukemia].
    Fujii H, Yashige H, Taniwaki M, Urata Y, Kuzuyama Y, Kitagawa Y, Horishi M, Suyama Y, Miyoshi M.
    Gan No Rinsho; 1990 Apr 15; 36(5):645-50. PubMed ID: 2109137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.